# Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

> **NCT06991348** · PHASE4 · RECRUITING · sponsor: **Carnot Laboratories** · enrollment: 128 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT06991348
- **Lead sponsor:** Carnot Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991348, "Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06991348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*